Search

Genetic Predisposition to Blood Cancer (Rare diseases)

The objectives of the group are:

Share and extend clinical knowledge on the diagnosis and treatment of hematologic malignancies with germline predisposition.

SWG Educational Activities

During the annual meeting of EHA, a scientific session was organized: “Mesenchymal stromal cells: guardians of tissue homeostasis”.

Sponsor and Fundraising Committee

Current committee members
Martin Dreyling, Germany (Chair)
Claire Harrison, United Kingdom (Vice-Chair)
Igor Aurer, Croatia (SWG Committee representative)
Arndt Borkhardt, Germany (Research Committee representative)
Konstanze Döhner, Germany (Education Committee representative)
Kirsten Grønbæk, Denmark (Councilor)
Frank Leebeek, The Netherlands (Councilor)
Mariane de Montalembert, France (Councilor)
David Rees, United Kingdom (Education…

Chairs and Members

Chair (2023–2026)Marieke Essers, German Cancer Research Center (German)

Co-chair (2023–2026)Elisa Laurenti, University of Cambridge (United Kingdom)

SWG Steering Committee members (2023–2026)
Konstantinos Kokkaliaris, Frankfurt University (German)
Mirjam Belderbos, Prinses Maxima Center Utrecht (The Netherlands)
Simona Valetta, University of Manchester (United Kingdom)
Members
David Kent (United Kingdom)
Nina Cabezas-Wallscheid…

Standards for functional precision medicine project update, December 2023

A project update from Prof Philipp Staber. We're confident that we'll successfully finish our SWG-initiated small research project, ‘standards for functional precision medicine (StFPM),’ within the next six months.

EHA policy on double awarding

EHA is guided by the concept of supporting as many young investigators/clinicians as possible in their career development. Therefore, double awarding is not allowed.